- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - AstraZeneca PLC - Imfinzi new dose receives positive EU CHMP opinion
AnnouncementREG - AstraZeneca PLC - Trixeo Aerosphere approved in the EU for COPD
AnnouncementREG - AstraZeneca PLC - Trastuzumab deruxtecan positive CHMP
AnnouncementREG - AstraZeneca PLC - AstraZeneca to acquire Alexion Pharmaceuticals Inc
AnnouncementRCS - Halix B.V. - HALIX Signs Agreement With AstraZeneca
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Crestor to be divested to Grünenthal in Europe
AnnouncementREG - AstraZeneca PLC - Forxiga approved in Japan for heart failure
AnnouncementREG - AstraZeneca PLC - AZD1222 vaccine effective against COVID-19
AnnouncementREG - AstraZeneca PLC - Imfinzi new dosing approved in the US
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - AstraZeneca PLC - Tezepelumab Phase III trial met primary endpoint
AnnouncementREG - AstraZeneca PLC - Calquence approved in the EU for CLL
AnnouncementREG - AstraZeneca PLC - Brilinta approved in the US in stroke
AnnouncementREG - AstraZeneca PLC - Lynparza approved in the EU for wider ovarian use
AnnouncementREG - AstraZeneca PLC - Lynparza approved in the EU for prostate cancer
Announcement